Synergistic Effect of EZH2 Knockdown and Irradiation Against Pancreatic Cancer Cells

被引：0
作者：
Gupta, Raavi
Agrawal, Raag
Martello-Rooney, Laura
Haseeb, M.
机构：
[1] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA
[2] SUNY Downstate, Brooklyn, NY USA
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1831
引用
收藏
页码：457A / 457A
页数：1
相关论文
共 50 条
  • [41] Repression of E-Cadherin by the Polycomb Group Protein EZH2 in Pancreatic Cancer
    Toll, A. D.
    Dasgupta, A.
    Potoczek, M.
    Kleer, C. G.
    Brody, J. R.
    Witkiewicz, A. K.
    LABORATORY INVESTIGATION, 2010, 90 : 372A - 372A
  • [42] Repression of E-Cadherin by the Polycomb Group Protein EZH2 in Pancreatic Cancer
    Toll, A. D.
    Dasgupta, A.
    Potoczek, M.
    Kleer, C. G.
    Brody, J. R.
    Witkiewicz, A. K.
    MODERN PATHOLOGY, 2010, 23 : 372A - 372A
  • [43] A polymorphism in the promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer patients
    Maftouh, Mina
    Avan, Amir
    Funel, Niccola
    Paolicchi, Elisa
    Vasile, Enrico
    Pacetti, Paola
    Vaccaro, Vanja
    Faviana, Pinuccia
    Campani, Daniela
    Caponi, Sara
    Mambrini, Andrea
    Boggi, Ugo
    Cantore, Maurizio
    Milella, Michele
    Peters, Godefridus J.
    Reni, Michele
    Giovannetti, Elisa
    PHARMACOGENOMICS, 2014, 15 (05) : 609 - 618
  • [44] Chromatin-Independent Interplay of NFATc1 and EZH2 in Pancreatic Cancer
    Patil, Shilpa
    Forster, Teresa
    Reutlinger, Kristina
    Kopp, Waltraut
    Versemann, Lennart
    Spitalieri, Jessica
    Gaedcke, Jochen
    Stroebel, Philipp
    Singh, Shiv K.
    Ellenrieder, Volker
    Neesse, Albrecht
    Hessmann, Elisabeth
    CELLS, 2021, 10 (12)
  • [45] Diverse involvement of EZH2 in cancer epigenetics
    Volkel, Pamela
    Dupret, Barbara
    Le Bourhis, Xuefen
    Angrand, Pierre-Olivier
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2015, 7 (02): : 175 - 193
  • [46] EZH2: a novel target for cancer treatment
    Ran Duan
    Wenfang Du
    Weijian Guo
    Journal of Hematology & Oncology, 13
  • [47] EZH2 accompanies prostate cancer progression
    Xin, Li
    NATURE CELL BIOLOGY, 2021, 23 (09) : 934 - 936
  • [48] Targeting EZH2 in neuroendocrine prostate cancer
    Puca, Loredana
    Gao, Dong
    Kossai, Myriam
    Marotz, Clarisse
    Mosquera, Juan Miguel
    MacDonald, Theresa Y.
    Park, Kyung
    Rao, Rema
    Sboner, Andrea
    Chen, Yu
    Rubin, Mark A.
    Beltran, Himisha
    CANCER RESEARCH, 2015, 75
  • [49] EZH2: a novel target for cancer treatment
    Duan, Ran
    Du, Wenfang
    Guo, Weijian
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [50] Treating human cancer by targeting EZH2
    Xu, Mengfei
    Xu, Chunyan
    Wang, Rui
    Tang, Qing
    Zhou, Qichun
    Wu, Wanyin
    Wan, Xinliang
    Mo, Handan
    Pan, Jun
    Wang, Sumei
    GENES & DISEASES, 2025, 12 (03)
12345